Coronary Stent Market Size, Share, Growth Analysis, By Product Type(Bare Metal Stents (BMS), Drug-Eluting Stents (DES), and Bioresorbable Vascular Scaffold (BVS)), By Biomaterial(Biomaterials, Polymeric Biomaterials, and Natural Biomaterials), By Region - Industry Forecast 2024-2031

Coronary Stent Market size was valued at USD 9.09 Billion in 2022 and is poised to grow from USD 9.39 Billion in 2023 to USD 12.17 Billion by 2031, at a CAGR of 3.3% during the forecast period (2024-2031).

The global coronary stent market has witnessed significant growth and advancements in recent years. The market growth is primarily driven by factors such as the increasing prevalence of cardiovascular diseases, rising geriatric population, and the growing adoption of minimally invasive procedures. The rise in cardiovascular diseases, including coronary artery disease, has led to a higher demand for coronary stents. Lifestyle changes, sedentary habits, and unhealthy diets contribute to the increasing incidence of these diseases worldwide. Additionally, the aging population is more susceptible to cardiovascular conditions, further fueling the demand for coronary stents. Technological advancements and innovations in stent designs have significantly improved patient outcomes and safety.

The development of drug-eluting stents (DES) and bioresorbable stents has reduced the risk of restenosis and improved long-term results. These advancements have led to a shift from traditional bare-metal stents to drug-eluting and bioresorbable stents, driving market growth. However, the coronary stent market faces certain challenges. One of the major challenges is the high cost associated with coronary stent procedures, including the cost of stents themselves and the implantation procedure. This can limit the adoption of stents in lower-income regions or by patients with limited financial resources. Stringent regulations and approval processes imposed by regulatory authorities also pose challenges to market growth. Manufacturers need to comply with various regulatory requirements, including safety and efficacy assessments, before their stents can be approved for use. These processes can be time-consuming and resource-intensive. Additionally, the potential complications associated with stent implantation, such as stent thrombosis, restenosis, and allergic reactions, present challenges for both patients and healthcare providers.

US Coronary Stent Market is poised to grow at a sustainable CAGR for the next forecast year.